Volunteer for Research on Depression
in New York City.
There are many causes of major depression. One strategy for understanding possible genetic
causes involves comparing the DNA from blood of brothers and sisters who suffer from this
illness.
Eligibility criteria for a genetic study of major depression ongoing at Columbia University
include: major depression before age 30; a living brother or sister who also has had major
depression; age 21-70 . Subjects will be asked to participate in an interview and to donate
a small amount of blood. Participants will be paid for their efforts.
If you think you may be eligible and would be interested in talking with a member of our
professional staff confidentially about this study, please contact:
Simona Noaghiul, MD, MPH
New York State Psychiatric Institute, Unit 24
New York, NY 10032
Ph: (212) 543-6520
http://www.nyspi.org/depression/
Email: noaghius@child.cpmc.columbia.edu
The same study as above in Philadelphia.
Study Two: (NYC) Long Term Treatment of Major Depression:
All entering patients with Major Depression receive 12 weeks of
open-label Prozac treatment, with no placebo. Responders are randomized
to 1 year of maintenance or a switch to placebo. Relapsers during
maintenance are removed from the study and given open treatment with
Prozac if they relapsed on placebo and alternate pharmacotherapy if they
relapsed on Prozac. Non-responders to Prozac will be given alternate
antidepressants for up to 3 more months. Most patients with unipolar or
bipolar 2 Major Depression without current alcohol or substance abuse
are eligible. Previous Prozac treatment does not necessarily exclude
potential subjects.
Study Three: (NYC) Depression and Alcohol Abuse.
Patients who are currently abusing alcohol and also have a depressive
disorder are eligible for a 12 week study of Prozac compared to
placebo. All patients get weekly individual counseling using a
behavioral model for controlling drinking. Responders get 6 months
follow up treatment with medication provided. Non-responders to
placebo at 12 weeks get a trial of Prozac; non-responders to Prozac
get alternate pharmacologic treatment which may include ReVia
(naltrexone) or other antidepressants. Most patients in generally good
health who do not need inpatient detoxification are eligible.
To volunteer for either of these studies please contact:
Patrick J. McGrath, M.D.
New York State Psychiatric Institute
722 West 168th Street
New York, New York 10032
Phone: 212-960-5764
Fax: 212-960-2326
Email: PJM5@Columbia.edu
Study Four: (NYC) Free treatment for 5 months in a research setting
Do you wish there were better treatment for depression?
With your help, there might be.
If you are depressed and between age 18-65, you may be eligible for a
research study involving brain imaging and medication treatment at
NO COST, to you at The New York State Psychiatric Institute/Columbia
University. We will provide 5 months of outpatient treatment for Major
Depressive Disorder at NO COST, to you as part of a treatment study.
Your participation in this study can help further our understanding of
depression and speed the recovery of others who suffer from depression
in the future. Inpatient treatment is also available. You will be paid up to
$415 for your time and effort if you are eligible and choose to participate.
For more information, please call (212) 543-1427 or
visit our website.
Study Five: Bipolar CHOICE Study at Cornell Medical Center in New York City
This federally funded study is being conducted at ten different medical centers
across the United States in individuals 18-68 years of age, diagnosed with bipolar
I or II disorder and having at least mild current symptoms. The study will test
whether lithium or quetiapine (Seroquel) in combination with other medications
usually prescribed for bipolar disorder is more effective. Participants must be
willing to be randomized to take lithium or Seroquel. This study lasts up to 6
months. Visits are once every 2 weeks for the first 2 months and then monthly
thereafter. Study participants will receive study-related treatment, research
medication and evaluation at no cost. Subjects receive $50 per visit For more
information please call the Affective Disorders Research Clinic at Weill Cornell
Medical Center.
Contact:
Courtney Shelly
Phone: 212-746-5705
Email: cos2003@med.cornell.edu
Return to Depression Central
Revised 11/20/11